Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propranolol and experimental myocardial infarction: substrate effects

L H Opie, M Thomas

    Postgraduate Medical Journal
    |January 1, 1976
    PubMed
    Summary

    Propranolol reduces heart damage during myocardial infarction by altering substrate metabolism, favoring glucose over fatty acids. This action may decrease infarct size and prevent adverse effects in experimental myocardial infarction.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cardiovascular prevention: lifestyle and statins--competitors or companions?

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2014
    Same author

    Sodium glucose co-transporter 2 (SGLT2) inhibitors: new among antidiabetic drugs.

    Cardiovascular drugs and therapy·2014
    Same author

    Hypertension, platelets, and inflammatory responses.

    Cardiovascular drugs and therapy·2014
    Same author

    The effect of left ventricular remodelling on soluble ST2 in a cohort of hypertensive subjects.

    Journal of human hypertension·2014
    Same author

    Aspirin in the prevention of cancer.

    Lancet (London, England)·2011
    Same author

    Hypertension, the changing pattern of drug usage.

    Cardiovascular journal of Africa·2009

    Area of Science:

    • Cardiology
    • Biochemistry
    • Pharmacology

    Background:

    • Propranolol is recognized for reducing ischemic damage in myocardial infarction.
    • It influences mechanical parameters affecting oxygen supply-demand balance in ischemic tissue.
    • Propranolol alters myocardial substrate uptake, decreasing free fatty acids and increasing glucose utilization.

    Purpose of the Study:

    • To investigate the role of propranolol's substrate-altering actions in mitigating myocardial infarction.
    • To explore how propranolol's effects on fatty acid and glucose uptake influence ischemic damage.
    • To determine if propranolol's metabolic effects contribute to preventing adverse effects in experimental myocardial infarction.

    Main Methods:

    • Studies involved assessing myocardial infarction models in dogs and isolated rat hearts.
    • Measurements included mechanical function, heart rate, and enzyme release.
    • Substrate perfusion with free fatty acids versus glucose was utilized to evaluate propranolol's effects.

    Main Results:

    • Propranolol decreases myocardial uptake of free fatty acids and increases glucose uptake.
    • It reduces enzyme release from isolated rat hearts during coronary ligation.
    • Propranolol causes more significant depression of mechanical function and heart rate when hearts are perfused with free fatty acids compared to glucose.

    Conclusions:

    • Propranolol may favorably alter developing myocardial infarction by modifying substrate supply to the ischemic zone.
    • The glucose-promoting and anti-lipolytic effects of propranolol are suggested to be crucial in reducing infarct size.
    • These metabolic actions may also be important in preventing undesirable side effects in experimental myocardial infarction.

    Related Experiment Videos